{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:48:19Z","timestamp":1794487699804,"version":"4.9.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["MOP 106706"],"award-info":[{"award-number":["MOP 106706"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CIHR Vanier Doctoral Fellowship","award":["200911CVG-217548-192773"],"award-info":[{"award-number":["200911CVG-217548-192773"]}]},{"DOI":"10.13039\/501100005247","name":"University of British Columbia","doi-asserted-by":"publisher","award":["6456"],"award-info":[{"award-number":["6456"]}],"id":[{"id":"10.13039\/501100005247","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CIHR Canadian Graduate Scholarships Master's","award":["6556"],"award-info":[{"award-number":["6556"]}]},{"name":"Four Year Doctoral Fellowship","award":["6456"],"award-info":[{"award-number":["6456"]}]},{"name":"Four Year Doctoral Fellowship","award":["6456"],"award-info":[{"award-number":["6456"]}]},{"DOI":"10.13039\/501100005309","name":"Alzheimer Society of","doi-asserted-by":"publisher","award":["1406"],"award-info":[{"award-number":["1406"]}],"id":[{"id":"10.13039\/501100005309","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Comissao Technica de Atribuicao de Bolsas para Estudos Pos-Graduados Macao","award":["12113"],"award-info":[{"award-number":["12113"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.bbadis.2015.10.005","type":"journal-article","created":{"date-parts":[[2015,10,17]],"date-time":"2015-10-17T14:12:19Z","timestamp":1445091139000},"page":"1027-1036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Reconstituted high-density lipoproteins acutely reduce soluble brain A\u03b2 levels in symptomatic APP\/PS1 mice"],"prefix":"10.1016","volume":"1862","author":[{"given":"J\u00e9r\u00f4me","family":"Robert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Stukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Button","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3408-9184","authenticated-orcid":false,"given":"Wai Hang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjia","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva","family":"Kulic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl L.","family":"Wellington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2015.10.005_bb0005","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","article-title":"Alzheimer disease in the United States (2010\u20132050) estimated using the 2010 census","volume":"80","author":"Hebert","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2015.10.005_bb0010","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.bbadis.2015.10.005_bb0015","first-page":"1","article-title":"Vascular contributions to cognitive impairment and dementia including Alzheimer's disease","author":"Snyder","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0020","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s007020200068","article-title":"Alzheimer disease and cerebrovascular pathology: an update","volume":"109","author":"Jellinger","year":"2002","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0025","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1161\/STROKEAHA.108.533174","article-title":"Cerebral amyloid angiopathy: progressive disruption of the neurovascular unit","volume":"40","author":"Zipfel","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.bbadis.2015.10.005_bb0030","doi-asserted-by":"publisher","first-page":"134","DOI":"10.17925\/ENR.2012.07.02.134","article-title":"Advances in our understanding of the pathophysiology, detection and management of cerebral amyloid angiopathy.","volume":"7","author":"Pontes-Neto","year":"2012","journal-title":"Eur Neurol. Rev."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0035","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1161\/STROKEAHA.110.595082","article-title":"Microinfarct pathology, dementia, and cognitive systems","volume":"42","author":"Arvanitakis","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.bbadis.2015.10.005_bb0040","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/S1474-4422(11)70307-6","article-title":"Cerebral microinfarcts: the invisible lesions","volume":"11","author":"Smith","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0045","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1212\/WNL.57.8.1447","article-title":"Cholesterol and neuropathologic markers of AD: a population-based autopsy study","volume":"57","author":"Launer","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2015.10.005_bb0050","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0197-4580(00)00096-8","article-title":"Midlife blood pressure and dementia: the Honolulu-Asia aging study","volume":"21","author":"Launer","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2015.10.005_bb0055","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1001\/archneur.62.10.1556","article-title":"Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease","volume":"62","author":"Kivipelto","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0060","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1212\/01.wnl.0000306313.89165.ef","article-title":"Central obesity and increased risk of dementia more than three decades later","volume":"71","author":"Whitmer","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2015.10.005_bb0065","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/ana.21557","article-title":"The brain in the age of old: the hippocampal formation is targeted differentially by diseases of late life","volume":"64","author":"Wu","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0070","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1001\/archneurol.2008.582","article-title":"Midlife and late-life obesity and the risk of dementia: cardiovascular health study","volume":"66","author":"Fitzpatrick","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0075","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S1474-4422(09)70236-4","article-title":"Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis","volume":"8","author":"Pendlebury","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0080","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000231980","article-title":"Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later","volume":"28","author":"Solomon","year":"2009","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0085","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1212\/WNL.0b013e3181f4d7f8","article-title":"Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study","volume":"75","author":"Ahtiluoto","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2015.10.005_bb0090","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hbm.20870","article-title":"Brain structure and obesity","volume":"31","author":"Raji","year":"2010","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0095","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1159\/000324134","article-title":"Type 2 diabetes and late-onset Alzheimer's disease","volume":"31","author":"Cheng","year":"2011","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0100","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1212\/WNL.0b013e318227b227","article-title":"Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline","volume":"77","author":"Debette","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2015.10.005_bb0105","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1161\/HYPERTENSIONAHA.110.163055","article-title":"Midlife and late-life blood pressure and dementia in Japanese elderly: the Hisayama study","volume":"58","author":"Ninomiya","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.bbadis.2015.10.005_bb0110","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1212\/WNL.0b013e31822f0435","article-title":"Glucose tolerance status and risk of dementia in the community: the Hisayama study","volume":"77","author":"Ohara","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2015.10.005_bb0115","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nrneurol.2011.2","article-title":"Epidemiology of Alzheimer disease","volume":"7","author":"Reitz","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0120","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1159\/000330020","article-title":"Vascular risk factors and dementia: 40-year follow-up of a population-based cohort","volume":"31","author":"R\u00f6nnemaa","year":"2011","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0125","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/archinternmed.2010.393","article-title":"Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia","volume":"171","author":"Rusanen","year":"2011","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0130","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1212\/WNL.0b013e3182190d09","article-title":"Midlife overweight and obesity increase late-life dementia risk: a population-based twin study","volume":"76","author":"Xu","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2015.10.005_bb0135","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/WAD.0b013e318222f0d4","article-title":"Central obesity in the elderly is related to late-onset Alzheimer disease","volume":"26","author":"Luchsinger","year":"2012","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0140","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1194\/jlr.R039479","article-title":"Regulation of signal transduction by HDL","volume":"54","author":"Mineo","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0145","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.111.066589","article-title":"Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport","volume":"125","author":"Rosenson","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2015.10.005_bb0150","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R037762","article-title":"High-density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease","author":"Riwanto","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0155","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1172\/JCI27352","article-title":"Intestinal ABCA1 directly contributes to HDL biogenesis in vivo","volume":"116","author":"Brunham","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0160","doi-asserted-by":"crossref","first-page":"14352","DOI":"10.1016\/S0021-9258(18)47945-8","article-title":"Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain","volume":"262","author":"Pitas","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0165","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/S0024-3205(97)00135-5","article-title":"Effects of triamcinolone on brain and cerebrospinal fluid apolipoprotein E levels in rats","volume":"60","author":"Chiba","year":"1997","journal-title":"Life Sci."},{"issue":"Pt 1","key":"10.1016\/j.bbadis.2015.10.005_bb0170","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1042\/bj3210145","article-title":"Marked increases in concentrations of apolipoprotein in the cerebrospinal fluid of poliovirus-infected macaques: relations between apolipoprotein concentrations and severity of brain injury","volume":"321","author":"Saito","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0175","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0304-3940(97)00558-2","article-title":"Cerebrospinal fluid apo E and apo a-I concentrations in early- and late-onset Alzheimer's disease","volume":"231","author":"Song","year":"1997","journal-title":"Neurosci. Lett."},{"issue":"Pt 3","key":"10.1016\/j.bbadis.2015.10.005_bb0180","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1177\/000456329803500310","article-title":"Apo A-I and apo E concentrations in cerebrospinal fluids of patients with acute meningitis","volume":"35","author":"Song","year":"1998","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0185","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0022-2275(20)32039-3","article-title":"Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin: cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer's disease","volume":"41","author":"Demeester","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0190","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000008157","article-title":"Age-dependent decline in the apolipoprotein E level in cerebrospinal fluid from control subjects and its increase in cerebrospinal fluid from patients with Alzheimer's disease","volume":"43","author":"Fukuyama","year":"2000","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0195","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0022-2275(20)31605-9","article-title":"Characterization of four lipoprotein classes in human cerebrospinal fluid","volume":"42","author":"Koch","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0200","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3109\/13547500903108423","article-title":"Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease","volume":"14","author":"Roher","year":"2009","journal-title":"Biomarkers"},{"key":"10.1016\/j.bbadis.2015.10.005_bb0205","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001156","article-title":"Intravenously injected human apolipoprotein A-I rapidly enters the central nervous system via the choroid plexus","volume":"3","author":"Stukas","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0210","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0197-4580(99)00103-7","article-title":"Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease","volume":"21","author":"Merched","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2015.10.005_bb0215","first-page":"1","article-title":"Apolipoprotein C-III is an amyloid-\u03b2-binding protein and an early marker for Alzheimer's Disease","author":"Shih","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0220","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/aje\/kwm027","article-title":"The relation between apolipoprotein A-I and dementia: the Honolulu-Asia aging study","volume":"165","author":"Saczynski","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0225","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1001\/archneurol.2010.297","article-title":"Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease","volume":"67","author":"Reitz","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0230","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1001\/jamaneurol.2013.5390","article-title":"Associations between serum cholesterol levels and cerebral amyloidosis","volume":"71","author":"Reed","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0235","first-page":"589","article-title":"Low levels of serum apolipoprotein A I and A II in senile dementia","volume":"48","author":"Kuriyama","year":"1994","journal-title":"Jpn. J. Psychiatry Neurol."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0240","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0009-8981(95)06115-T","article-title":"Marked decrease of plasma apolipoprotein AI and AII in Japanese patients with late-onset non-familial Alzheimer's disease.","volume":"239","author":"Kawano","year":"1995","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbadis.2015.10.005_bb0245","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2014.05.1749","article-title":"Plasma proteins predict conversion to dementia from prodromal disease","author":"Hye","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0250","doi-asserted-by":"publisher","first-page":"36958","DOI":"10.1074\/jbc.M110.127829","article-title":"Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease","volume":"285","author":"Lewis","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0255","doi-asserted-by":"publisher","first-page":"36945","DOI":"10.1074\/jbc.M110.127738","article-title":"Apolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP\/PS1DeltaE9 mice","volume":"285","author":"Lefterov","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0260","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1097\/MOL.0000000000000020","article-title":"Reconstituted HDL for the acute treatment of acute coronary syndrome","volume":"24","author":"Krause","year":"2013","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0265","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1021\/jm4005847","article-title":"Molecules that mimic apolipoprotein A-I: potential agents for treating atherosclerosis","volume":"57","author":"Leman","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0270","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrd4279","article-title":"HDL-targeted therapies: progress, failures and future","volume":"13","author":"Kingwell","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0275","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1046\/j.1423-0410.1996.7130155.x","article-title":"Production and characterization of a reconstituted high density lipoprotein for therapeutic applications","volume":"71","author":"Lerch","year":"1996","journal-title":"Vox Sang."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0280","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1001\/jama.297.15.jpc70004","article-title":"Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial","volume":"297","author":"Tardif","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.bbadis.2015.10.005_bb0285","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1161\/CIRCRESAHA.108.182063","article-title":"Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque","volume":"103","author":"Shaw","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0290","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1161\/CIRCULATIONAHA.109.870709","article-title":"Reconstituted high-density lipoprotein attenuates platelet function in individuals with type 2 diabetes mellitus by promoting cholesterol efflux","volume":"120","author":"Calkin","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2015.10.005_bb0295","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jacc.2008.12.008","article-title":"Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes","volume":"53","author":"Patel","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0300","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1177\/1074248411426144","article-title":"Reconstituted HDL elicits marked changes in plasma lipids following single-dose injection in C57Bl\/6 mice","volume":"17","author":"Chen","year":"2012","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0305","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/ni.2784","article-title":"High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3","volume":"15","author":"De Nardo","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0310","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1161\/ATVBAHA.113.302832","article-title":"Inhibition of arthritis in the Lewis rat by apolipoprotein A-I and reconstituted high-density lipoproteins","volume":"34","author":"Wu","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0315","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.bbalip.2011.08.014","article-title":"The LXR agonist GW3965 increases apoA-I protein levels in the central nervous system independent of ABCA1","volume":"1821","author":"Stukas","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2015.10.005_bb0320","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M049940","article-title":"LCAT deficiency does not impair amyloid metabolism in APP\/PS1 mice","author":"Stukas","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0325","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1750-1326-6-86","article-title":"Resorufin analogs preferentially bind cerebrovascular amyloid: potential use as imaging ligands for cerebral amyloid angiopathy","volume":"6","author":"Han","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0330","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R035725","article-title":"The proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond","author":"Shah","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2015.10.005_bb0335","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.nbd.2009.03.007","article-title":"Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer's disease","volume":"34","author":"Handattu","year":"2009","journal-title":"Neurobiol. Dis."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443915002999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443915002999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T17:19:58Z","timestamp":1718126398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443915002999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0925443915002999"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2015.10.005","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reconstituted high-density lipoproteins acutely reduce soluble brain A\u03b2 levels in symptomatic APP\/PS1 mice","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2015.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}